Promotes healthcare access and affordability by requiring insurers to pass on rebates to insureds and analyzing barriers to cell and gene therapy.

This bill mandates that insurers pass on at least 80% of estimated rebates to insureds by reducing cost-sharing. It also requires the health policy commission and the secretary of health and human services to analyze and report on barriers to access for cell and gene therapies, proposing solutions to address these barriers. The report must be made available electronically and filed with relevant state officials by July 30.

Promotes healthcare access and affordability by requiring insurers to pass on rebates to insureds and analyzing barriers to cell and gene therapy.

This bill mandates that insurers pass on at least 80% of estimated rebates to insureds by reducing cost-sharing. It also requires the health policy commission and the secretary of health and human services to analyze and report on barriers to access for cell and gene therapies, proposing solutions to address these barriers. The report must be made available electronically and filed with relevant state officials by July 30.